Acute cardiac care & resuscitation

Bleeding complications in patients with out-of-hospital cardiac arrest treated with cangrelor and oral P2Y12 inhibitors

Eur Heart J Acute Cardiovasc CarePublished retrospective chart review study

Main finding · Bleeding Academic Research Consortium (BARC) 3-5 bleedingResult — go to the resultAdjusted odds ratio 0.79 95% CI 0.45–1.39

Authors' conclusion

In patients with OHCA undergoing PCI, BARC 3-5 bleeding occurred at a similar rate in patients receiving either cangrelor and transition to an oral P2Y12 inhibitor or an oral P2Y12 inhibitor alone.

Study context

Population
Patients with out-of-hospital cardiac arrest (OHCA) undergoing percutaneous coronary intervention (PCI), treated with conventional cardiopulmonary resuscitation (CPR) or extracorporeal CPRincluded between January 2016 and March 2025
Participants
414 patients
Exposure
Cangrelor and transition to an oral P2Y12 inhibitor or an oral P2Y12 inhibitor alone
  • Cangrelor groupn = 267
  • Oral P2Y12 inhibitor groupn = 147reference
Outcome
Bleeding Academic Research Consortium (BARC) 3-5 bleeding
Follow-up
30 days

Main finding

As reported in the abstract

Adjusted odds ratio

0.79

95% CI 0.45–1.39

By group

Cangrelor groupvs oral P2Y12 inhibitor group
adjusted OR 0.79 (95% CI 0.45–1.39)

Observational data: associations, not effects.

Further findings

OutcomeCangrelor groupOral P2Y12 inhibitor groupAdjusted OR (95% CI)
Stent thrombosis, extracorporeal CPR subgroupWithout reaching statistical significance2.1%4.5%0.32 (0.03–3.14)

Bleeding Academic Research Consortium (BARC) 3-5 bleeding, conventional and extracorporeal CPR subgroups · 6, 24 and 48 h

Similar between the cangrelor group and the oral P2Y12 inhibitor group

Original publication

Bleeding complications in patients with out-of-hospital cardiac arrest treated with cangrelor and oral P2Y12 inhibitors. Eur Heart J Acute Cardiovasc Care. Published 6 June 2025. doi:10.1093/ehjacc/zuaf082

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.